agonist
[용어속성] Term
TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target
Pharmacology
[키워드] adjuvant
agonist
Biomarker
clinical testing
Complication
coronavirus 2
Coronavirus disease 2019
COVID-19
disorder
drug candidate
drug target identification
Epidemiology
explain
favor
healthcare
hyperinflammation
Hypothesis
identify
immune
immunology
individual
Intervention
introduced
lack
late stage
limitation
manifestation
manuscript
mechanism of action
medical need
mitochondrial DNA
modulating
novel coronavirus disease
onset of disease
pathogen
pathogenesis of COVID-19
pathophysiology
Patient
prevented
preventive measures
Prophylactic
reached
receptor
resource
respiratory
risk
severe acute respiratory syndrome coronavirus 2
severe COVID-19
target
theory
therapeutic
thrombotic complication
TLR9
toll-like receptor 9
Treatment
Vaccine
vulnerable patient
[DOI] 10.3389/fphar.2020.601685 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2020.601685 PMC 바로가기 [Article Type] Pharmacology
PPAR Gamma: From Definition to Molecular Targets and Therapy of Lung Diseases
Review
[키워드] activity
acute respiratory distress
agonist
Anti-inflammatory
AP-1
Bacteria
Biomarker
caused
clinically
Definition
distress
Effect
eicosanoid
exacerbated
expression of gene
Gene Expression
Glucose
highlight
Inflammation
Inflammatory mediators
inflammatory stimuli
inhibit
intracellular signaling
kinases
ligands
lung
Lung disease
Lung injury
mechanism
metabolism
molecular
Molecular targets
morbidity and mortality
nuclear
Pathologies
peroxisome
Phosphorylation
post-translational modifications
PPARγ
PPARγ
Protein
pulmonary diseases
receptor
regulate
Regulation
shown
STAT
target
targets
therapeutic potential
therapy
Transcription
transcription factor
transcription factors
virus
[DOI] 10.3390/ijms22020805 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/ijms22020805 PMC 바로가기 [Article Type] Review
Targeting immunometabolism to treat COVID-19
Targeting Immunometabolism
[키워드] agonist
anti-viral agents
Antiviral
antiviral therapy
Cell
COVID-19
COVID-19 crisis
derivative
disease severity
elicit
Evidence
functions
hyper-inflammatory response
Immune cell
immunometabolism
immunomodulatory
immunomodulatory property
indicate
inflammatory phase
Inflammatory response
innate immune reprogramming
investigated
Macrophage
metabolite
offer
potential therapy
pro-inflammatory
recent
receptor
Research
researcher
SARS-CoV-2
shown
targeting
the disease
treat
undergo
viral infection
with COVID-19
zoonoses
[DOI] 10.1093/immadv/ltab013 PMC 바로가기 [Article Type] Targeting Immunometabolism
[DOI] 10.1093/immadv/ltab013 PMC 바로가기 [Article Type] Targeting Immunometabolism
Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature
Review article
[키워드] absence
ADA
agonist
Anti-diabetic drugs
appraisal
article
benefit
carried
case sery
clinician
coronavirus disease
COVID-19
database
Glucose
Google Scholar
Hospitalization
Hospitalized
inhibitor
literature
medRxiv
metformin
Mortality
no evidence of
observational studies
observational study
outcome
outcomes
Patient
peptide
Randomized controlled trial
RCT
RCTs
receptor
reported
Result
retrieved
retrospective cohort
SARS-CoV-2
severity
sick
sodium
type 2 diabete
[DOI] 10.1016/j.dsx.2020.12.026 [Article Type] Review article
[DOI] 10.1016/j.dsx.2020.12.026 [Article Type] Review article
Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions
Regular Article
[키워드] Abstract
Acetylcholine
Acetylcholine-binding protein
ACh, Acetylcholine
AChAcetylcholine
AChBP, Acetylcholine-binding protein
AChBPAcetylcholine-binding protein
acute respiratory distress syndrome
agonist
agonists
Anti-inflammatory
approved
ARDS, acute respiratory distress syndrome
ARDSacute respiratory distress syndrome
Basic Local Alignment Search Tool
binding
BLAST, Basic Local Alignment Search Tool
BLASTBasic Local Alignment Search Tool
Central nervous system
CHARMM, Chemistry at Harvard Macromolecular Mechanics
CHARMMChemistry at Harvard Macromolecular Mechanics
Chemistry at Harvard Macromolecular Mechanics
cholinergic
Cholinergic agonists
clinical manifestation
CNS, Central Nervous System
CNSCentral Nervous System
complexes
condition
constant number
coronavirus
CoV, coronavirus
CoVcoronavirus
COVID-19
DCD, single precision binary FORTRAN
DCDsingle precision binary FORTRAN
disorder
dysregulation
ECD, extracellular domain
ECDextracellular domain
energy
epitope
extracellular domain
glycoprotein
HADDOCK, High Ambiguity Driven protein-protein DOCKing
HADDOCKHigh Ambiguity Driven protein-protein DOCKing
High Ambiguity Driven protein-protein DOCKing
High-mobility group protein 1
HMGB1, High-mobility group protein 1
HMGB1High-mobility group protein 1
homologous
hospitalized COVID-19 patients
Hypothesis
IL, interleukin
ILInterleukin
in vitro
in vivo
Inflammatory
Interaction
interleukin
Jak2, Janus kinases 2
Jak2Janus kinases 2
Janus kinases 2
LBD, Ligand Binding Domain
LBDLigand Binding Domain
lig, ligand
Ligand
Ligand Binding Domain
ligligand
MD, molecular dynamics
MDMolecular Dynamics
MDS, Molecular Dynamics Simulations
MDSMolecular Dynamics Simulations
MERS, Middle East respiratory syndrome
MERSMiddle East Respiratory Syndrome
Middle East respiratory syndrome
molecular dynamics
molecular dynamics simulations
nAChRs, nicotinic acetylcholine receptors
nAChRsnicotinic acetylcholine receptors
NAMD, Nanoscale Molecular Dynamics
NAMDNanoscale Molecular Dynamics
Nanoscale Molecular Dynamics
National Center for Biotechnology Information
NCBI, National Center for Biotechnology Information
NCBINational Center for Biotechnology Information
NCS, Nicotinic Cholinergic System
NCSNicotinic Cholinergic System
neurological
NF-kB, nuclear factor kappa-light-chain-enhancer of activated B cells
NF-kBnuclear factor kappa-light-chain-enhancer of activated B cells
Nicotinic acetylcholine receptors
Nicotinic Cholinergic System
NPT, constant number, pressure, energy
NPTconstant number
nuclear factor kappa-light-chain-enhancer of activated B cells
NVT, constant number, volume, energy
NVTconstant number
pandemic
Particle Mesh Ewald
patients with COVID-19
PDB, Protein Data Bank
PDBProtein Data Bank
PME, Particle Mesh Ewald
PMEParticle Mesh Ewald
pressure
Prevalence
Prevent
PRODIGY, PROtein binDIng enerGY prediction
PRODIGYPROtein binDIng enerGY prediction
PROtein binDIng enerGY prediction
Protein Data Bank
PyMOL, Python Molecule
PyMOLPython Molecule
Python Molecule
RBD, receptor binding domain
RBDReceptor Binding Domain
receptor
Receptor binding domain
RMSD, Root-mean-square deviation
RMSDRoot-mean-square deviation
Root-mean-square deviation
SARS - 2 Spike Subunit 1 protein
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 S1
SARS-CoV-2 S1, SARS - 2 Spike Subunit 1 protein
SARS-CoV-2 S1SARS - 2 Spike Subunit 1 protein
SARS, Severe acute respiratory syndrome
SARSSevere Acute Respiratory Syndrome
Saturation Transfer Difference Nuclear Magnetic Resonance
Scientific community
Severe acute respiratory syndrome
severe COVID-19
severe symptoms
signal transducer and activator of transcription 3
significantly
single precision binary FORTRAN
smoker
smoking
spike
spike glycoprotein
STAT3, signal transducer and activator of transcription 3
STAT3signal transducer and activator of transcription 3
STD NMR, Saturation Transfer Difference Nuclear Magnetic Resonance
STD NMRSaturation Transfer Difference Nuclear Magnetic Resonance
substrate
Symptom
System
the SARS-CoV-2
Therapeutic approach
therapeutic intervention
therapeutic option
TNF, Tumor Necrosis Factor
TNFTumor Necrosis Factor
toxins
triggering
tumor necrosis factor
Visual Molecular Dynamics
VMD, Visual Molecular Dynamics
VMDVisual Molecular Dynamics
Volume
[DOI] 10.1016/j.toxrep.2020.12.013 PMC 바로가기 [Article Type] Regular Article
[DOI] 10.1016/j.toxrep.2020.12.013 PMC 바로가기 [Article Type] Regular Article
Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019
Pharmacology
[키워드] acute respiratory distress syndrome
acute respiratory syndrome
agonist
anti-inflammatory activity
approach
ARDS
cannabinoid
caused
coronavirus
Coronavirus disease 2019
coronavirus disease-2019
COVID-19
COVID-19 patient
Cytokine storm
death
develop
effective
Express
Hyperactivation
hyperimmune
Immune cell
immune system
intense investigation
multi-organ failure
patients with COVID-19
proportion
receptor
receptors
respiratory
Respiratory disease
resulting
severe acute respiratory syndrome coronavirus 2
storm
syndrome
systemic inflammation
treat
Treatment
[DOI] 10.3389/fphar.2020.589438 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2020.589438 PMC 바로가기 [Article Type] Pharmacology
Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia
코비드19-폐렴 환자의 고유량 21% 산소 에어로졸에서 아데노신의 치료 효과
Research Article
[키워드] 24 hour
24 hours
active treatments
adenosine
agonist
Analysis
ARDS
bronchospasm
change
clinical trials
control group
controlled clinical trials
death
demonstrated
Effect
enrolled
experimental group
feature
hemodynamic
historical control
Hospitalized
Infection
Inflammatory
inflammatory lung disease
Inhaled
interstitial
lack
lung
Lung disease
Lung inflammation
mice
Mitigation
moderate
outcome
oxygen
oxygenated
PaO
Patient
patients treated
preclinical studies
preclinical study
radiological
receive
receiving
receptor
recorded
reported
Result
SARS-CoV-2 RNA
SARS-CoV2 infection
severe lung inflammation
severity
significant increase
syndrome
the disease
therapeutic effect
Treatment
Trigger
Ventilation
were recorded
[DOI] 10.1371/journal.pone.0239692 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0239692 PMC 바로가기 [Article Type] Research Article
SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate
Article
[키워드] addition
agonist
agonists
airway
anti-inflammatory activity
antioxidant
Antiviral
antiviral activity
approved
biopsy
cell lines
cellular
clinically
consequence
coronavirus 2
COVID-19
COVID-19 pathology
COVID-19 patients
cytopathogenic effect
decrease
disease
effective
fumarate
Gene Expression
Herpe
host inflammatory response
immunology
induce
Infection
Inflammatory responses
inhibit
inhibitory effect
limit
mechanism
Microbiology
Nrf2
pathogenic
pathogenic virus
pathogenic viruses
pathway
pro-inflammatory response
Replication
required
respiratory
reveal
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV2
SARS-CoV2 infection
suppressed
type I interferon
vaccinia
virus
virus replication
Zika virus
[DOI] 10.1038/s41467-020-18764-3 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41467-020-18764-3 PMC 바로가기 [Article Type] Article